Clinical significance of the advanced lung cancer inflammation index in patients with limited-stage small cell lung cancer treated with chemoradiotherapy

The aim of the study was to investigate the prognostic significance of the advanced lung cancer inflammation index (ALI) in patients with limited-stage small-cell lung cancer (LS-SCLC) undergoing definite chemo-radiotherapy (CRT). We included 87 patients with LS-SCLC from South Korea, treated betwee...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Scientific reports 2024-05, Vol.14 (1), p.10347-10, Article 10347
Hauptverfasser: Seo, Bo Mi, Choi, Jiin, Chang, Boksoon, Kim, Bo-Guen, Park, Tai Sun, Lee, Hyun, Moon, Ji-Yong, Kim, Sang-Heon, Kim, Tae-Hyung, Yoo, Seung-Jin, Park, Hae Jin, Yoon, Ho Joo, Sohn, Jang Won, Lee, Seung Hyeun, Park, Dong Won
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The aim of the study was to investigate the prognostic significance of the advanced lung cancer inflammation index (ALI) in patients with limited-stage small-cell lung cancer (LS-SCLC) undergoing definite chemo-radiotherapy (CRT). We included 87 patients with LS-SCLC from South Korea, treated between 2005 and 2019 with definite CRT. ALI was calculated using body mass index, serum albumin, and neutrophil–lymphocyte ratio. We categorized 38 patients into the high ALI group (ALI ≥ 44.3) and 48 into the low ALI group (ALI 
ISSN:2045-2322
2045-2322
DOI:10.1038/s41598-024-61145-9